Format

Send to

Choose Destination
Endokrynol Pol. 2020;71(1):102-103. doi: 10.5603/EP.a2019.0045. Epub 2019 Sep 30.

Worsening of unrecognized tumour-induced osteomalacia with inadvertent use of recombinant human parathyroid hormone.

Author information

1
Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
2
Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
3
Department of General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
4
Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. bhadadask@rediffmail.com.

Abstract

Not required for Clinical Vignette.

KEYWORDS:

fragility fracture; hypophosphataemia; teriparatide; tumour-induced osteomalacia

PMID:
31566250
DOI:
10.5603/EP.a2019.0045
Free full text

Supplemental Content

Full text links

Icon for Via Medica Medical Publishers
Loading ...
Support Center